scholarly article | Q13442814 |
P50 | author | Karina S Machado | Q57130802 |
P2093 | author name string | Karina S Machado | |
Osmar Norberto de Souza | |||
Marcelo Cohen | |||
Elisangela M L Cohen | |||
P2860 | cites work | Application of a Theory of Enzyme Specificity to Protein Synthesis | Q24620284 |
Genomic-scale prioritization of drug targets: the TDR Targets database | Q24635333 | ||
Flexible ligand docking to multiple receptor conformations: a practical alternative | Q24650066 | ||
Mechanism of thioamide drug action against tuberculosis and leprosy | Q24676495 | ||
Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data | Q27640586 | ||
Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis | Q27730411 | ||
VMD: visual molecular dynamics | Q27860554 | ||
CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues | Q27860729 | ||
The Amber biomolecular simulation programs | Q27860745 | ||
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions | Q27861128 | ||
Triclosan targets lipid synthesis | Q28279853 | ||
Automated docking of flexible ligands: applications of AutoDock | Q28285420 | ||
Combining docking and molecular dynamic simulations in drug design | Q33245994 | ||
Accommodating protein flexibility in computational drug design | Q33825095 | ||
Automated docking of ligands to antibodies: methods and applications. | Q33849933 | ||
A geometric approach to macromolecule-ligand interactions | Q34280176 | ||
Testing a flexible-receptor docking algorithm in a model binding site | Q34309041 | ||
Computational methods for biomolecular docking. | Q34396832 | ||
Target flexibility in molecular recognition | Q36266696 | ||
Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex. | Q36536450 | ||
An improved relaxed complex scheme for receptor flexibility in computer-aided drug design | Q36838120 | ||
Flexible ligand-flexible protein docking in protein kinase systems | Q36998393 | ||
Target flexibility: an emerging consideration in drug discovery and design | Q37240137 | ||
Managing protein flexibility in docking and its applications | Q37382489 | ||
Molecular dynamics simulation studies of the wild-type, I21V, and I16T mutants of isoniazid-resistant Mycobacterium tuberculosis enoyl reductase (InhA) in complex with NADH: toward the understanding of NADH-InhA different affinities | Q43203047 | ||
Computational drug design accommodating receptor flexibility: the relaxed complex scheme | Q43992973 | ||
An inorganic iron complex that inhibits wild-type and an isoniazid-resistant mutant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis. | Q44739712 | ||
Protein flexibility in ligand docking and virtual screening to protein kinases. | Q44786754 | ||
Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy. | Q52005770 | ||
Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates. | Q54125830 | ||
Conformational selection of protein kinase A revealed by flexible-ligand flexible-protein docking | Q57131485 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | Mycobacterium tuberculosis | Q130971 |
P304 | page(s) | S7 | |
P577 | publication date | 2011-12-22 | |
P1433 | published in | BMC Genomics | Q15765854 |
P1476 | title | Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations | |
P478 | volume | 12 Suppl 4 |
Q39420787 | Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides |
Q39180968 | Insights into the bonding pattern for characterizing the open and closed state of the substrate-binding loop in Mycobacterium tuberculosis InhA. |
Q37128281 | Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii |
Q27311652 | Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies |
Q90241957 | The importance of the quaternary structure to represent conformational ensembles of the major Mycobacterium tuberculosis drug target |
Search more.